JP4418155B2 - 変異天花粉蛋白 - Google Patents

変異天花粉蛋白 Download PDF

Info

Publication number
JP4418155B2
JP4418155B2 JP2002517821A JP2002517821A JP4418155B2 JP 4418155 B2 JP4418155 B2 JP 4418155B2 JP 2002517821 A JP2002517821 A JP 2002517821A JP 2002517821 A JP2002517821 A JP 2002517821A JP 4418155 B2 JP4418155 B2 JP 4418155B2
Authority
JP
Japan
Prior art keywords
mtcs
tcs
amino acid
cells
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002517821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505635A (ja
JP2004505635A5 (cg-RX-API-DMAC7.html
Inventor
イ−バオ ケ,
ニエ,フイリン
Original Assignee
ベイジン エスティエム バイオテク リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 00119553 external-priority patent/CN1283630A/zh
Application filed by ベイジン エスティエム バイオテク リミテッド filed Critical ベイジン エスティエム バイオテク リミテッド
Publication of JP2004505635A publication Critical patent/JP2004505635A/ja
Publication of JP2004505635A5 publication Critical patent/JP2004505635A5/ja
Application granted granted Critical
Publication of JP4418155B2 publication Critical patent/JP4418155B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2002517821A 2000-08-02 2001-07-18 変異天花粉蛋白 Expired - Fee Related JP4418155B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN 00119553 CN1283630A (zh) 2000-08-02 2000-08-02 一种天花粉蛋白突变体及制备方法
CNB011031026A CN1152051C (zh) 2000-08-02 2001-01-18 一种天花粉蛋白突变体及制备方法
PCT/CN2001/001178 WO2002012537A2 (en) 2000-08-02 2001-07-18 Mutant trichosanthin

Publications (3)

Publication Number Publication Date
JP2004505635A JP2004505635A (ja) 2004-02-26
JP2004505635A5 JP2004505635A5 (cg-RX-API-DMAC7.html) 2009-02-26
JP4418155B2 true JP4418155B2 (ja) 2010-02-17

Family

ID=25739487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517821A Expired - Fee Related JP4418155B2 (ja) 2000-08-02 2001-07-18 変異天花粉蛋白

Country Status (6)

Country Link
US (1) US7157552B2 (cg-RX-API-DMAC7.html)
EP (1) EP1307480B1 (cg-RX-API-DMAC7.html)
JP (1) JP4418155B2 (cg-RX-API-DMAC7.html)
CN (2) CN1152051C (cg-RX-API-DMAC7.html)
AU (1) AU2002214919A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002012537A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312175C (zh) * 2004-09-09 2007-04-25 北京大学 天花粉蛋白突变体及其编码基因
CN101469016B (zh) * 2007-12-29 2011-09-07 上海交通大学医学院 天花粉蛋白衍生肽及其应用
WO2012091118A1 (ja) * 2010-12-29 2012-07-05 国立大学法人秋田大学 子宮外妊娠の治療剤
CN110412264A (zh) * 2019-08-01 2019-11-05 临沂大学 一种用于天花粉真伪鉴定的双抗夹心酶联免疫试剂盒及其使用鉴别方法
CN112501190A (zh) * 2021-02-04 2021-03-16 广东药科大学附属第一医院 一种重组质粒、美白剂、其制备方法及相关应用
CN114317466B (zh) * 2022-01-04 2023-10-27 中山大学附属第三医院 一种突变acc1蛋白及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128460A (en) 1989-04-04 1992-07-07 Genelabs Incorporated Recombinant trichosanthin and coding sequence
US5077390A (en) 1989-04-04 1991-12-31 Genelabs, Incorporated Purified trichosanthin and method of preparation
DE69222636T2 (de) 1991-04-15 1998-02-05 American Biosciences Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen
US5541110A (en) * 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica

Also Published As

Publication number Publication date
US7157552B2 (en) 2007-01-02
JP2004505635A (ja) 2004-02-26
CN1208343C (zh) 2005-06-29
US20040197853A1 (en) 2004-10-07
WO2002012537A3 (en) 2002-05-02
WO2002012537A2 (en) 2002-02-14
EP1307480A4 (en) 2005-03-30
EP1307480A2 (en) 2003-05-07
HK1061872A1 (en) 2004-10-08
EP1307480B1 (en) 2013-09-18
CN1336381A (zh) 2002-02-20
CN1468257A (zh) 2004-01-14
AU2002214919A1 (en) 2002-02-18
CN1152051C (zh) 2004-06-02

Similar Documents

Publication Publication Date Title
US20200157146A1 (en) Controlled modulation of amino acid side chain length of peptide antigens
AU762035B2 (en) Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
KR101997756B1 (ko) 패혈증 예방 또는 치료용 조성물
CA2337743C (en) Tumor antigen based on products of the tumor suppressor gene wt1
EP3998077B1 (en) Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
WO1998046642A1 (en) MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
KR19990022654A (ko) 보호 면역 반응을 증강시키는 방법
CA2355334A1 (en) Pharmaceutical preparations and methods for inhibiting tumors
ES2534308T3 (es) Uso de formas solubles de CD83 y ácidos nucleicos que las codifican para el tratamiento o prevención de enfermedades
WO2015055148A1 (zh) Yap蛋白抑制多肽及其应用
SK287523B6 (sk) Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby
JP2004505635A (ja) 変異天花粉蛋白
WO2006028497A2 (en) Active recombinant human lysozyme
US7479539B1 (en) Hedgehog fusion proteins
CN100390200C (zh) 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
CN1312175C (zh) 天花粉蛋白突变体及其编码基因
WO1998052972A1 (en) Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents
RU2858296C2 (ru) Полипептиды, содержащие мутантные формы человеческого vegf-а с реаранжировками дисульфидных связей, и композиции, содержащие их
US6387875B1 (en) Method of use for murine leukaemia inhibitory factor-binding protein (mLBP)
US7175848B1 (en) Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin
CN1752211B (zh) 用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
WO1994003492A1 (en) Interleukin-6 variants and uses therefor
US20030219421A1 (en) Calbindin-D28k protection against glucocorticoid induced cell death
WO2024021383A1 (zh) gp96及其在治疗肌萎缩侧索硬化的用途
KR20230120543A (ko) c-Met의 에피토프를 포함하는 암 백신 및 이의 용도

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080922

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081121

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081222

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20081222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090925

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20091009

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091110

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091127

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121204

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121204

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131204

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees